Table 2:

ROI analysis and tract-specific analysis of FA values in patients with iNPH and control subjects^a

	iNPH (n = 20)	Controls (n = 20)
ROI analysis
Corpus callosum:
a) Genu	0.71 ± 0.07	0.78 ± 0.06
b) Anterior third of body	0.58 ± 0.07	0.64 ± 0.06
c) Posterior third of body	0.55 ± 0.09^b	0.69 ± 0.06
d) Splenium	0.68 ± 0.11^b	0.78 ± 0.05
e) Juxtacortical WM in frontal lobe	0.50 ± 0.03^b/0.50 ± 0.04^b	0.61 ± 0.04/0.62 ± 0.04
f) Juxtacortical WM in parietal lobe	0.44 ± 0.04^b/0.44 ± 0.05^b	0.58 ± 0.04/0.56 ± 0.06
g) WM around posterior horn of lateral ventricle	0.27 ± 0.07^b/0.27 ± 0.06^b	0.39 ± 0.07/0.34 ± 0.05
h) WM around anterior horn of lateral ventricle	0.25 ± 0.07^b/0.24 ± 0.07^b	0.36 ± 0.06/0.32 ± 0.06
i) Anterior limbs of internal capsule	0.49 ± 0.05/0.49 ± 0.03	0.48 ± 0.04/0.49 ± 0.05
j) WM around posterior horn of lateral ventricle	0.48 ± 0.03^b/0.48 ± 0.03^b	0.60 ± 0.05/0.61 ± 0.04
k) WM in temporal lobe	0.51 ± 0.04/0.51 ± 0.03	0.52 ± 0.04/0.52 ± 0.03
Tract-specific analysis
Area 1	0.41 ± 0.04^b/0.41 ± 0.03^b	0.45 ± 0.03/0.46 ± 0.03
Area 2	0.53 ± 0.06^b/0.55 ± 0.05^b	0.43 ± 0.04/0.44 ± 0.05
Area 3	0.69 ± 0.04^b/0.71 ± 0.04^b	0.62 ± 0.05/0.65 ± 0.05
Area 4	0.60 ± 0.05/0.62 ± 0.05	0.58 ± 0.05/0.61 ± 0.04